April 20, 2024

Veterinary Software Market to Reach US$ 1.02 Bn by 2030

The global veterinary software market size was valued at USD 490.0 million in 2020, and is predicted to be worth around USD 1.02 billion by 2030, registering a CAGR of 8.90% during the forecast period 2022 to 2030.

Veterinary Software

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39133

Veterinary Software Market Growth Factors

An increase in the prevalence of zoonotic diseases is a key factor for the growth of this market. Rising prevalence has triggered the demand for animal health diagnostics and monitoring services, which is expected to propel market growth over the forecast period. The growing adoption of integrated software systems for diagnostics and treatment is anticipated to fuel the market growth over the following years.

Pet health information systems that enable real-time analysis of the prevalence of diseases will help researchers develop therapeutics. The incorporation of these solutions in laboratories is another growth propeller for veterinary reference laboratories. Moreover, zoonotic diseases pose a major public health burden, especially in tropical regions due to the lack of funds and healthcare infrastructure. An increase in the willingness to pay for animal healthcare is expected to fuel the adoption of animal health diagnostics and imaging software over the forecast period.

Increasing demand for Practice Management Systems (PMS) from veterinary practitioners is a key contributor to the market growth. In addition, growing awareness regarding the benefits of the use of software solutions and an increasing number of clinical visits by pet owners are expected to boost the adoption of software solutions in veterinary practices in the coming years. The animal health industry is impacted by an increase in companion pet ownership and concerns over pet health. A growing focus on the efficiency and safety of livestock production is also another growth propeller.

Report Coverage

Report Scope Details
Market Size US$ 1.02 billion by 2030
Growth Rate CAGR of 8.90% From 2022 to 2030
Largest Market North America
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Product, Delivery Mode, Practice Type, End use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned IDEXX Laboratories, Inc.; Hippo Manager Software, Inc.; VetZ Limited; Esaote SpA; Henry Schein, Inc.; Patterson Companies, Inc.; ClienTrax; VIA Information Systems; Onward Systems, Inc

By Product Analysis

Practice management software accounted for the largest revenue share of over 65.0% in 2021 due to the growing demand from consumers and the cost-effective nature of these systems.

These systems help practitioners to support and record different standards of care protocols, healthcare recommendations, keep track of the patient’s health with invoicing and billing, resource management, inventory tracking, and overall management of treatment procedures.

The growing adoption of information systems in healthcare practices has significantly changed the way of care delivery to patients over the past decades. Novel veterinary practice management software permits hospitals and clinics to directly access results from diagnostic labs, hence bringing down the treatment time considerably and making life easier for pet proprietors.

Cloud-based practice management systems are the best examples of technologically advanced and cost-efficient software solutions for pet health practices. The veterinary field has been following the paths of the human healthcare sector, which further supports the overall market growth.

By Delivery Mode Analysis

On-premise solutions dominated the overall industry in 2021 with a revenue share of over 50.0% owing to their low cost and widespread availability of these services. However, the cost of these platforms is higher as it includes the cost of the overall system and hardware and software package.

The ease of access with proper IT infrastructure used in the deployment of the cloud/web-based solutions helps in increasing productivity and generating more profits for the organization. The high cost associated with their deployment is expected to limit their adoption by emerging players.

The deployment of cloud-based solutions is expected to change the dynamics. These services offer a single platform through which patients, researchers, and practitioners access medical information. These platforms minimize the risk of data theft by offering a secure platform for sharing information and enabling veterinarians to keep track of information.

By Practice Type Analysis

The food-producing animals segment held the dominant share of over 40.0% in 2021 due to the higher demand for cost-effective products to maintain livestock health. Increasing demand for such products from vet medicine manufacturers to control the process of manufacturing, maintain information related to product storage and quality.

According to the Food and Agriculture Organization, in the emerging economies, food animal products account for one-third of human protein consumption. This leads to an increase in the demand for improving livestock productivity, which is critical to meeting the dietary needs of the growing human population.

The introduction of veterinary control management systems that help in the identification and registration of livestock and maintenance of records of farms including owner details is expected to propel the adoption of these solutions over the coming years.

The equine segment is expected to grow lucratively in the years to come owing to an increase in companion animal ownership, awareness, and demand for efficient pet care. An increase in pet ownership is a consequence of associated health benefits for humans.

By End-use Analysis

The hospitals/clinics segment dominated the market for veterinary software and held a revenue share of over 50.0% in 2021. The adoption of these services is driven by technological advancements in pet care and this is anticipated to serve as a growth opportunity.

These advancements include the advent of efficient information management systems and pet owner mobile technology. A high focus on innovation in animal health has given rise to certain measures that are being implemented or in the process of implementation, which are fueling the market growth prospects.

The reference laboratories segment is expected to witness lucrative growth in the following years. These labs are developing various technologies for the detection and monitoring of various diseases. Government animal welfare authorities and policymakers are encouraging farmers through targeted incentives about the adoption of veterinary care practices for food-producing species.

By Regional Analysis

The North American market held the largest revenue share of over 40.0% in 2021 and is expected to maintain its position throughout the forecast period. The presence of well-established companies, advanced healthcare IT infrastructure, and high spending capacity of pet owners are responsible for the largest revenue share of this segment.

The Asia Pacific market is anticipated to register a lucrative CAGR of 11.1% during the forecast period due to the growing demand for veterinary practice management, which is a result of a continuously growing livestock population, increasing demand for animal-derived food products, and rising pet adoption in this region.

Read also @ MHealth Apps Market Growth at a CAGR of 11.7% from 2022 to 2030

Major Key Players Covered in The Veterinary Software Market Report include

  • IDEXX Laboratories, Inc.
  • Hippo Manager Software, Inc.
  • VetZ Limited
  • Esaote SpA
  • Henry Schein, Inc.
  • Patterson Companies, Inc.
  • ClienTrax
  • VIA Information Systems
  • Onward Systems, Inc.

Veterinary Software Market Segmentation

  • By Product
    • Practice Management Software
    • Imaging Software
  • By Delivery Mode
    • On-premise
    • Cloud/Web-based
  • By Practice Type
    • Small Animals
    • Mixed Animals
    • Equine
    • Food-producing Animals
    • Others
  • By End-use
    • Hospitals/Clinics
    • Reference Laboratories
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Netherlands
      • Switzerland
      • Sweden
      • Ireland
      • Poland
    • Asia Pacific
      • Japan
      • China
      • India
      • Indonesia
      • Thailand
      • Australia
      • South Korea
      • Philippines
      • Malaysia
      • Singapore
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East and Africa
      • South Africa
      • Saudi Arabia
      • Turkey
      • Iran
      • United Arab Emirates
      • Israel

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Practice TypeAnalysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Veterinary Software Market, By Product

7.1.  Veterinary Software Market, by Product, 2021-2030

7.1.1.    Practice Management Software

7.1.1.1.        Market Revenue and Forecast (2019-2030)

7.1.2.    Imaging Software

7.1.2.1.        Market Revenue and Forecast (2019-2030)

Chapter 8.  Global Veterinary Software Market, By Delivery Mode

8.1.  Veterinary Software Market, by Delivery Mode, 2021-2030

8.1.1.    On-premise

8.1.1.1.        Market Revenue and Forecast (2019-2030)

8.1.2.    Cloud/Web-based

8.1.2.1.        Market Revenue and Forecast (2019-2030)

Chapter 9.  Global Veterinary Software Market, By Practice Type

9.1.  Veterinary Software Market, by Distribution Channel, 2021-2030

9.1.1.    Small Animals

9.1.1.1.        Market Revenue and Forecast (2019-2030)

9.1.2.    Mixed Animals

9.1.2.1.        Market Revenue and Forecast (2019-2030)

9.1.3.    Equine

9.1.3.1.        Market Revenue and Forecast (2019-2030)

9.1.4.    Food-producing Animals

9.1.4.1.        Market Revenue and Forecast (2019-2030)

Chapter 10.      Global Veterinary Software Market, By End-use

10.1.        Veterinary Software Market, by End-use, 2021-2030

10.1.1.  Hospitals/Clinics

10.1.1.1.      Market Revenue and Forecast (2019-2030)

10.1.2.  Reference Laboratories

10.1.2.1.      Market Revenue and Forecast (2019-2030)

Chapter 11.      Global Veterinary Software Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2019-2030)

11.1.2.  Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.1.3.  Market Revenue and Forecast, by Practice Type(2019-2030)

11.1.4.  Market Revenue and Forecast, by End-use (2019-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2019-2030)

11.1.5.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.1.5.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.1.5.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2019-2030)

11.1.6.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.1.6.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.1.6.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2019-2030)

11.2.2.  Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.2.3.  Market Revenue and Forecast, by Practice Type(2019-2030)

11.2.4.  Market Revenue and Forecast, by End-use (2019-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2019-2030)

11.2.5.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.2.5.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.2.5.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2019-2030)

11.2.6.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.2.6.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.2.6.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2019-2030)

11.2.7.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.2.7.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.2.7.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2019-2030)

11.2.8.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.2.8.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.2.8.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2019-2030)

11.3.2.  Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.3.3.  Market Revenue and Forecast, by Practice Type(2019-2030)

11.3.4.  Market Revenue and Forecast, by End-use (2019-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2019-2030)

11.3.5.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.3.5.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.3.5.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2019-2030)

11.3.6.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.3.6.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.3.6.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2019-2030)

11.3.7.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.3.7.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.3.7.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2019-2030)

11.3.8.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.3.8.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.3.8.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2019-2030)

11.4.2.  Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.4.3.  Market Revenue and Forecast, by Practice Type(2019-2030)

11.4.4.  Market Revenue and Forecast, by End-use (2019-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2019-2030)

11.4.5.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.4.5.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.4.5.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2019-2030)

11.4.6.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.4.6.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.4.6.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2019-2030)

11.4.7.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.4.7.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.4.7.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2019-2030)

11.4.8.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.4.8.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.4.8.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2019-2030)

11.5.2.  Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.5.3.  Market Revenue and Forecast, by Practice Type(2019-2030)

11.5.4.  Market Revenue and Forecast, by End-use (2019-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2019-2030)

11.5.5.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.5.5.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.5.5.4.      Market Revenue and Forecast, by End-use (2019-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2019-2030)

11.5.6.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.5.6.3.      Market Revenue and Forecast, by Practice Type(2019-2030)

11.5.6.4.      Market Revenue and Forecast, by End-use (2019-2030)

Chapter 12.  Company Profiles

12.1.              IDEXX Laboratories, Inc.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Hippo Manager Software, Inc.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              VetZ Limited

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Esaote SpA

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Henry Schein, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Patterson Companies, Inc.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              ClienTrax

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              VIA Information Systems

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Onward Systems, Inc.

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39133 

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Leave a Reply

Your email address will not be published. Required fields are marked *